Nightly Business Report — June 9, 2014

Tonight on Nightly Business Report, why does Merck want to spend about $4 billion to buy a drug company that specializes in Hepatitis C treatments?
And, Time Inc. spins off from its parent company but can it make it on its own?

This entry was posted in NBR Shows. Bookmark the permalink.

Leave a Reply